Share Prices & Company Research

Market News

24 Mar 2021 | 14:45

Glaxo fires former Trump vaccine tsar over harassment allegations

(Sharecast News) - GlaxoSmithKline said on Wednesday that it has fired Moncef Slaoui as chair of the board of directors of Galvani, in which it owns a majority stake, amid allegations of sexual harassment. The pharmaceuticals company said Slaoui, who led the Trump administration's Covid-19 vaccine programme, has been accused of sexual harassment and inappropriate conduct towards an employee.

The misconduct is alleged to have taken place "several years ago" when Slaoui was a Glaxo employee.

Following receipt of a letter containing the allegations, GlaxoSmithKline has immediately initiated an investigation with an experienced law firm.

"The investigation of Dr. Slaoui's conduct substantiated the allegations and is ongoing," it said. "Dr. Slaoui's behaviours are wholly unacceptable. They represent an abuse of his leadership position, violate company policies, and are contrary to the strong values that define GSK's culture. The company expects everyone at GSK to behave in accordance with its values, especially its leaders where its standards are the highest. Sexual harassment and any abuse of leadership position are strictly prohibited and will not be tolerated."
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.